Physician profile
Robert Wilcox
NPI 1265413140
$5,601.62
in general payments reported to CMS, 2019-2025
48 companies · $1,929 in 2025
The $1,929 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,278 · 2020: $245 · 2021: $252 · 2022: $472 · 2023: $459 · 2024: $966 · 2025: $1,929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,300 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,299.68 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,255.18 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals Lp | $543.25 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Phathom Pharmaceuticals, INC. | $402.58 | 2024-2025 | Voquezna |
| Abbvie INC. | $351.52 | 2019-2025 | |
| Pfizer INC. | $228.48 | 2019-2025 | |
| Glaxosmithkline, LLC. | $221.98 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $208.39 | 2019-2025 | Kisunla, Zepbound, Mounjaro |
| Shield Therapeutics INC | $205.04 | 2025 | |
| Exact Sciences Corporation | $161.69 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $153.14 | 2024-2025 | Gemtesa |
| Allergan, INC. | $140.07 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $137.89 | 2024-2025 | Rexulti |
| Dexcom, INC. | $134.05 | 2023-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Ironshore Pharmaceuticals INC. | $121.40 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.10 | 2019-2025 | Xifaxan |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wilcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.